The Finding
A comprehensive analysis of lightweight LLMs (under 7B parameters) on biomedical named entity recognition (NER) tasks found that smaller, specialized models match or exceed the performance of 100B+ parameter frontier models. The study tested models from 1B to 7B parameters against GPT-5.5 and Claude Opus 4.7 on extracting drug names, gene variants, disease terms, and protein interactions from medical literature.
- Best small model (BioMistral-7B): 94.2% F1 score on biomedical NER
- GPT-5.5: 93.8% F1 score — slightly worse than the specialized small model
- Claude Opus 4.7: 95.1% F1 score — marginally better but at 50x the cost
- Cost comparison: Small model costs $0.02 per 1K documents vs $2.40 for GPT-5.5
The Efficiency Trend
This is part of a broader trend: specialized small models are becoming the smart choice for domain-specific tasks. The economics are compelling:
- Small models run on consumer hardware (no cloud dependency)
- Training a specialized 7B model costs ~$500 vs millions for frontier models
- Inference latency is 10-50x lower for real-time applications
- Data privacy is preserved when running locally
This confirms what I've been saying: you don't need GPT-5.5 for everything. For domain-specific tasks — biomedical NER, legal document analysis, financial data extraction — a well-trained 7B model is often better, faster, and dramatically cheaper than a frontier model. The future of AI isn't just bigger models. It's the right model for the right task.